---
figid: PMC8972168__fphar-13-820927-g004
figtitle: Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus
  Treatment Towards Personalized Medicine
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Caenorhabditis elegans
pmcid: PMC8972168
filename: fphar-13-820927-g004.jpg
figlink: /pmc/articles/PMC8972168/figure/F4/
number: F4
caption: Signal pathway activated by GC through complex formation with HSP70, HSP90,
  p23, FKBP52, and GR. GC-GR complex formation will activate other signals in the
  nucleus and mitochondria.
papertitle: Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus
  Treatment Towards Personalized Medicine.
reftext: Melisa Intan Barliana, et al. Front Pharmacol. 2022;13:820927.
year: '2022'
doi: 10.3389/fphar.2022.820927
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: Genetic polymorphism | pharmacokinetics | pharmacodynamics | systemic lupus
  erthematosus | precision medicine
automl_pathway: 0.9532567
figid_alias: PMC8972168__F4
figtype: Figure
redirect_from: /figures/PMC8972168__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8972168__fphar-13-820927-g004.html
  '@type': Dataset
  description: Signal pathway activated by GC through complex formation with HSP70,
    HSP90, p23, FKBP52, and GR. GC-GR complex formation will activate other signals
    in the nucleus and mitochondria.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSPA1A
  - HSPA4
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - FKBP4
  - TMEM245
  - PTGS2
  - PPID
  - PPIF
  - HSP90B2P
  - TGFBRAP1
  - HSPD1
  - hsp-70
  - hsp-90
  - COX2
  - trap-1
  - hsp-60
---
